Monitor the company's share price and any announcement of a reverse stock split implementation. The 180-day compliance period provides a timeline; if the stock remains below $1.00, the company will likely need to execute the reverse split. The activist stake (SC 13D/A filed Oct 2) adds pressure for strategic action, possibly including a sale or restructuring.
Price Chart
Executive Summary
Genenta Science received a Nasdaq deficiency notice for failing to maintain a minimum $1.00 bid price for 30 consecutive days. The company has 180 days (until April 14, 2027) to regain compliance, with a potential additional 180-day extension. A reverse stock split (1:10 to 1:20) has been authorized by shareholders but not yet implemented. This delisting risk is a material negative signal for the stock, especially given the company's low share price and the activist context.
Key Facts
- Nasdaq notified Genenta on October 16, 2026 of non-compliance with the $1.00 minimum bid price rule (30 consecutive business days below $1.00 from Sep 3 to Oct 15, 2026).
- Initial compliance period ends April 14, 2027; a second 180-day extension may be available if other listing standards are met.
- Shareholders have approved a reverse stock split (1:10 to 1:20) which the Board may implement to cure the deficiency.
- The company holds a 19% equity interest in Sòphia High Tech with an option to increase to 51% at a pre-agreed valuation.
Financial Impact
Delisting risk is material; failure to regain compliance could lead to Nasdaq delisting, severely impairing liquidity and access to capital. The reverse stock split, if executed, would mechanically boost the share price but does not change the underlying business fundamentals.
Risk Factors
- Failure to regain compliance could lead to Nasdaq delisting, reducing liquidity and investor confidence.
- Reverse stock split may not be sufficient if the underlying business does not improve.
- The company's pivot to a strategic consolidator in Italian national security sectors is unproven and carries execution risk.
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3385875 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 6-K | $0.6300 | awaiting T+60 | — | $0.6240 (−0.95%) |
Oct 21, 2026 5d ago | 6-K | $0.6301 | awaiting T+60 | — | $0.6240 (+0.97%) |
Oct 21, 2026 5d ago | Press Release | $0.6301 | awaiting T+60 | — | $0.6240 (+0.97%) |
Oct 13, 2026 13d ago | 6-K | $0.6602 | awaiting T+60 | — | $0.6240 (+5.48%) |
Oct 7, 2026 19d ago | 6-K | $0.7101 | awaiting T+60 | — | $0.6240 (−12.13%) |
Oct 2, 2026 24d ago | SC 13D/A | $0.7450 | awaiting T+60 | — | $0.6240 (−16.24%) |
Jul 22, 2026 13w ago | Press Release | $1.64 $0.6694 | ▼ −59.18% | ▼ −62.44% | $0.6240 (−61.95%) |
Jun 26, 2026 17w ago | 6-K | $1.80 $0.7040 | ▼ −60.89% | ▼ −65.27% | $0.6240 (−65.33%) |
Jun 17, 2026 18w ago | 6-K | $1.84 $0.8408 | ▼ −54.30% | ▼ −57.45% | $0.6240 (−66.09%) |
Jun 16, 2026 18w ago | 6-K | $1.87 $0.8613 | ▼ −53.94% | ▼ −54.94% | $0.6240 (−66.63%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers